Establish scaled up ExoPTEN Production
Finalize product characterization
ODD Approval
Preclinical experiments for IND submission
OMPD Approval QC/QA and IND preparation
IND submission Expected for Phase I/IIa Human trials
Phase I/IIa SCI Phase I/IIa GlaucomaEXO-Therapy JV/licensing
